Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Lineage relationship of prostate cancer cell types based on gene expression (2011)

  • Authors:
  • USP affiliated authors: VENCIO, RICARDO ZORZETTO NICOLIELLO - FFCLRP
  • USP Schools: FFCLRP
  • DOI: 10.1186/1755-8794-4-46
  • Subjects: NEOPLASIAS PROSTÁTICAS; EXPRESSÃO GÊNICA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1186/1755-8794-4-46 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by
    Informações sobre o Citescore
  • Título: BMC Medical Genomics

    ISSN: 1755-8794

    Citescore - 2017: 3.41

    SJR - 2017: 1.688

    SNIP - 2017: 0.847


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FCLRP2203596pcd 2203596 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PASCAL, Laura E.; VÊNCIO, Ricardo Zorzetto Nicoliello; VESELLA, Robert L.; et al. Lineage relationship of prostate cancer cell types based on gene expression. BMC Medical Genomics, London, v. 4, p. 1-13, 2011. DOI: 10.1186/1755-8794-4-46.
    • APA

      Pascal, L. E., Vêncio, R. Z. N., Vesella, R. L., Ware, C. B., Vêncio, E. F., Denyer, G., & Liu, A. (2011). Lineage relationship of prostate cancer cell types based on gene expression. BMC Medical Genomics, 4, 1-13. doi:10.1186/1755-8794-4-46
    • NLM

      Pascal LE, Vêncio RZN, Vesella RL, Ware CB, Vêncio EF, Denyer G, Liu A. Lineage relationship of prostate cancer cell types based on gene expression. BMC Medical Genomics. 2011 ; 4 1-13.
    • Vancouver

      Pascal LE, Vêncio RZN, Vesella RL, Ware CB, Vêncio EF, Denyer G, Liu A. Lineage relationship of prostate cancer cell types based on gene expression. BMC Medical Genomics. 2011 ; 4 1-13.

    Referências citadas na obra
    Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003, 100 (7): 3983-3988. 10.1073/pnas.0530291100.
    Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine. 1997, 3 (7): 730-737. 10.1038/nm0797-730.
    Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65 (23): 10946-10951. 10.1158/0008-5472.CAN-05-2018.
    Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics, 2000. CA: A Cancer Journal for Clinicians. 2000, 50 (1): 7-33. 10.3322/canjclin.50.1.7.
    Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA: Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. Journal of Andrology. 1992, 13 (6): 465-475.
    Aboseif S, El-Sakka A, Young P, Cunha G: Mesenchymal reprogramming of adult human epithelial differentiation. Differentiation. 1999, 65 (2): 113-118. 10.1046/j.1432-0436.1999.6520113.x.
    Pascal LE, Goo YA, Vencio RZ, Page LS, Chambers AA, Liebeskind ES, Takayama TK, True LD, Liu AY: Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes. BMC Cancer. 2009, 9: 317-10.1186/1471-2407-9-317.
    Pascal LE, Vencio RZ, Page LS, Liebeskind ES, Shadle CP, Troisch P, Marzolf B, True LD, Hood LE, Liu AY: Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes. BMC Cancer. 2009, 9: 452-10.1186/1471-2407-9-452.
    Epstein JI: An update of the Gleason grading system. J Urol. 2010, 183 (2): 433-440. 10.1016/j.juro.2009.10.046.
    Sobel RE, Sadar MD: Cell lines used in prostate cancer research: a compendium of old and new lines--part 1. J Urol. 2005, 173 (2): 342-359. 10.1097/01.ju.0000141580.30910.57.
    Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, Vessella RL: LuCaP 35: a new model of prostate cancer progression to androgen independence. Prostate. 2003, 55 (4): 239-246. 10.1002/pros.10198.
    True LD, Buhler K, Quinn J, Williams E, Nelson PS, Clegg N, Macoska JA, Norwood T, Liu A, Ellis W, et al: A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49. Am J Pathol. 2002, 161 (2): 705-715. 10.1016/S0002-9440(10)64226-5.
    Damjanov I, Horvat B, Gibas Z: Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Lab Invest. 1993, 68 (2): 220-232.
    Ware CB, Nelson AM, Blau CA: A comparison of NIH-approved human ESC lines. Stem cells. 2006, 24 (12): 2677-2684. 10.1634/stemcells.2005-0452.
    Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA: Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA. 2003, 100 (23): 13350-13355. 10.1073/pnas.2235735100.
    Pascal LE, Vencio RZ, Goo YA, Page LS, Shadle CP, Liu AY: Temporal expression profiling of the effects of secreted factors from prostate stromal cells on embryonal carcinoma stem cells. Prostate. 2009, 69 (12): 1353-1365. 10.1002/pros.20982.
    Oudes AJ, Campbell DS, Sorensen CM, Walashek LS, True LD, Liu AY: Transcriptomes of human prostate cells. BMC Genomics. 2006, 7: 92-10.1186/1471-2164-7-92.
    Pascal LE, Oudes AJ, Petersen TW, Goo YA, Walashek LS, True LD, Liu AY: Molecular and cellular characterization of ABCG2 in the prostate. BMC Urol. 2007, 7: 6-10.1186/1471-2490-7-6.
    Pascal LE, Deutsch EW, Campbell DS, Korb M, True LD, Liu AY: The urologic epithelial stem cell database (UESC) - a web tool for cell type-specific gene expression and immunohistochemistry images of the prostate and bladder. BMC Urol. 2007, 7: 19-10.1186/1471-2490-7-19.
    Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, Coleman IM, Eichner LJ, Nelson PS, Liu AY: Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics. 2008, 9: 246-10.1186/1471-2164-9-246.
    Freedland SJ, Pantuck AJ, Paik SH, Zisman A, Graeber TG, Eisenberg D, McBride WH, Nguyen D, Tso CL, Belldegrun AS: Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system. Prostate. 2003, 55 (4): 299-307. 10.1002/pros.10226.
    Freedland SJ, Seligson DB, Liu AY, Pantuck AJ, Paik SH, Horvath S, Wieder JA, Zisman A, Nguyen D, Tso CL, et al: Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate. 2003, 55 (1): 71-80. 10.1002/pros.10202.
    Oudes AJ, Roach JC, Walashek LS, Eichner LJ, True LD, Vessella RL, Liu AY: Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression. BMC Cancer. 2005, 5: 86-10.1186/1471-2407-5-86.
    Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, Bigler SA, Curtis D, Lange PH: Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin Cancer Res. 1996, 2 (6): 1039-1048.
    Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003, 4 (2): 249-264. 10.1093/biostatistics/4.2.249.
    Marzolf B, Deutsch EW, Moss P, Campbell D, Johnson MH, Galitski T: SBEAMS-Microarray: database software supporting genomic expression analyses for systems biology. BMC Bioinformatics. 2006, 7: 286-10.1186/1471-2105-7-286.
    Bonkhoff H, Remberger K: Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate. 1996, 28 (2): 98-106. 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J.
    Oka M, Tagoku K, Russell TL, Nakano Y, Hamazaki T, Meyer EM, Yokota T, Terada N: CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol Biol Cell. 2002, 13 (4): 1274-1281. 10.1091/mbc.02-01-0600.
    Dennis JE, Esterly K, Awadallah A, Parrish CR, Poynter GM, Goltry KL: Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration. Stem cells. 2007, 25 (10): 2575-2582. 10.1634/stemcells.2007-0204.
    Liu AY, True LD: Characterization of prostate cell types by CD cell surface molecules. Am J Pathol. 2002, 160 (1): 37-43. 10.1016/S0002-9440(10)64346-5.
    Liu AY, Roudier MP, True LD: Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. Am J Pathol. 2004, 165 (5): 1543-1556. 10.1016/S0002-9440(10)63412-8.
    Liu AY, Brubaker KD, Goo YA, Quinn JE, Kral S, Sorensen CM, Vessella RL, Belldegrun AS, Hood LE: Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines. Prostate. 2004, 60 (2): 98-108. 10.1002/pros.20031.
    Leong KG, Wang BE, Johnson L, Gao WQ: Generation of a prostate from a single adult stem cell. Nature. 2008, 456 (7223): 804-808. 10.1038/nature07427.
    Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, et al: Integrative molecular concept modeling of prostate cancer progression. Nat Genet. 2007, 39 (1): 41-51. 10.1038/ng1935.
    Eaton CL, Colombel M, van der Pluijm G, Cecchini M, Wetterwald A, Lippitt J, Rehman I, Hamdy F, Thalman G: Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer. Prostate. 2010, 70 (8): 875-882.
    Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, Hu YP, Price SM, Abate-Shen C, Shen MM: A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature. 2009, 461 (7263): 495-500. 10.1038/nature08361.
    Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON: Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA. 2010, 107 (6): 2610-2615. 10.1073/pnas.0913873107.
    Guzman-Ramirez N, Voller M, Wetterwald A, Germann M, Cross NA, Rentsch CA, Schalken J, Thalmann GN, Cecchini MG: In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate. 2009, 69 (15): 1683-1693. 10.1002/pros.21018.
    Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, et al: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005, 310 (5748): 644-648. 10.1126/science.1117679.
    Hurwitz AA, Foster BA, Allison JP, Greenberg NM, Kwon ED: The TRAMP mouse as a model for prostate cancer. Current protocols in immunology. Edited by: John E Coligan, et al. 2001, Chapter 20 (Unit 20): 25.
    Pascal LE, Ai J, Vêncio RZN, Vêncio EF, Zhou Y, Page LS, True LD, Wang Z, Liu AY: Differential inductive signaling of prostate tumor-associated stromal cells compared to normal tissue stromal mesenchyme cells. Cancer Microenvironment. 2011, 4 (1): 51-59. 10.1007/s12307-010-0061-4.
    Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG: PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res. 2008, 68 (6): 1820-1825. 10.1158/0008-5472.CAN-07-5878.
    Wei C, Guomin W, Yujun L, Ruizhe Q: Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?. Cancer Biology & Therapy. 2007, 6 (5): 763-768. 10.4161/cbt.6.5.3996.
    Tang Y, Hamburger AW, Wang L, Khan MA, Hussain A: Androgen deprivation and stem cell markers in prostate cancers. International Journal of Clinical and Experimental Pathology. 2009, 3 (2): 128-138.
    Birnbaum D, Bertucci F, Ginestier C, Tagett R, Jacquemier J, Charafe-Jauffret E: Basal and luminal breast cancers: basic or luminous? (review). Int J Oncol. 2004, 25 (2): 249-258.
    Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59 (19): 5002-5011.
    Walensky LD, Coffey DS, Chen TH, Wu TC, Pasternack GR: A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. Cancer Res. 1993, 53 (19): 4720-4726.
    Slack JM: Stem cells in epithelial tissues. Science. 2000, 287 (5457): 1431-1433. 10.1126/science.287.5457.1431.
    Collins AT, Habib FK, Maitland NJ, Neal DE: Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. Journal of Cell Science. 2001, 114 (Pt 21): 3865-3872.